Froedtert Hospital
Froedtert Hospital
Milwaukee, Wisconsin, United States24 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| ELEVATE-HFpEF Clinical Study | cardiovascular disorder, heart disorder, heart failure | Recruiting | Not applicable | 2026-10-02 | NCT06678841 | |
| REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE | Ventricular Outflow Obstruction, aortic valve disorder, aortic valve stenosis, cardiovascular disorder, heart disorder, heart valve disorder | Recruiting | Not stated | 2026-09-24 | NCT06777368 | |
| Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT) | Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Status Epilepticus, nervous system disorder, visual epilepsy | Recruiting | Phase 3 | 2026-09-17 | NCT06907173 | |
| Fosamprenavir for Laryngopharyngeal Upper Airway Tissue Treatment and Enzyme Reduction | Deglutition Disorders, Digestive System Diseases, Laryngopharyngeal Reflux, digestive system disorder, dyskinesia of esophagus, esophageal disorder, gastroesophageal reflux disease, laryngeal disorder, respiratory system disorder | Recruiting | Phase 2 | 2026-09-10 | NCT04383262 | |
| HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial | Femoral Fractures, Hip Injuries, Leg Injuries, bone fracture, hip fracture, injury | Recruiting | Not applicable | 2026-08-26 | NCT04743765 | |
| Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial | Digestive System Diseases, Digestive System Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Skin and Connective Tissue Diseases, Thoracic Neoplasms, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, benign urinary system neoplasm, breast cancer, breast disorder, breast neoplasm, cervix disorder, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, endometrium neoplasm, female reproductive system disorder, female reproductive system neoplasm, intestinal disorder, lung cancer, lung disorder, lung neoplasm, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder, rectal disorder, respiratory system disorder, respiratory tract neoplasm, skin disorder, urinary bladder cancer, urinary bladder disorder, urinary bladder neoplasm, urinary system disorder, uterine disorder | Recruiting | Not applicable | 2026-08-20 | NCT07227077 | |
| Master Protocol to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors | Neoplasms by Histologic Type, Neoplasms, Adipose Tissue, Neoplasms, Connective and Soft Tissue, connective tissue neoplasm, liposarcoma, myxoid liposarcoma, neoplasm, sarcoma, synovial sarcoma | Active, not recruiting | Phase 2 | 2026-08-11 | NCT03967223 | |
| Adoptive Cell Therapy Long-term Follow-up (LTFU) Study | neoplasm | Enrolling by invitation | Phase 1 | 2026-08-11 | NCT03391778 | |
| Utility of Mucosal Impedance Device in Chronic Esophageal Disorders: | Deglutition Disorders, Digestive System Diseases, Eosinophilia, Hemic and Lymphatic Diseases, Hypersensitivity, Immediate, digestive system disorder, dyskinesia of esophagus, eosinophilic esophagitis, esophageal disorder, esophagitis, gastroenteritis, gastroesophageal reflux disease, hematologic disorder, immune system disorder, leukocyte disorder | Recruiting | Not stated | 2026-07-27 | NCT07227506 | |
| Intensive Postpartum Antihypertensive Treatment | Infections, Toxemia | Active, not recruiting | Phase 3 | 2026-07-20 | NCT05687344 | |
| Delayed Primary Closure Using Negative Pressure Wound Therapy | Infections, Intraabdominal Infections | Active, not recruiting | Not applicable | 2026-07-10 | NCT04042259 | |
| A Study to Learn How Well Dupilumab Works in Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis and the Side Effects it May Have | Digestive System Diseases, Eosinophilia, Eosinophilic enteropathy, Hemic and Lymphatic Diseases, Hypersensitivity, Immediate, digestive system disorder, eosinophilic esophagitis, eosinophilic gastroenteritis, esophageal disorder, esophagitis, gastroenteritis, hematologic disorder, immune system disorder, leukocyte disorder | Active, not recruiting | Phase 2 | 2026-07-01 | NCT05831176 | |
| High Dose Re-Irradiation Utilizing Advanced Deformable Image Registration (DIR) and Individualized Organ At Risk (OAR) Dose Calculations With Organ Specific Toxicity Analysis | Solid Tumor | Recruiting | Not applicable | 2026-06-30 | NCT05301101 | |
| Anticoagulation in ICH Survivors for Stroke Prevention and Recovery | Arrhythmias, Cardiac, Hemorrhage, Intracranial Hemorrhages, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, heart disorder, intracerebral hemorrhage, nervous system disorder, vascular disorder | Recruiting | Phase 3 | 2026-05-08 | NCT03907046 | |
| Fueling Labor: Protein Supplementation for Intrapartum Glucose Control | Female Urogenital Diseases and Pregnancy Complications, Nutritional and Metabolic Diseases, Urogenital Diseases, diabetes mellitus, endocrine system disorder, gestational diabetes, glucose metabolism disease, metabolic disease, pregnancy disorder | Not yet recruiting | Not applicable | 2026-05-06 | NCT07571343 | |
| Intra- and Inter-fraction Changes in Radiation Therapy | cancer, neoplasm | Recruiting | Not stated | 2026-05-06 | NCT02344121 | |
| Brain Oxygen Optimization in Severe TBI, Phase 3 | Brain Injuries, Traumatic, Craniocerebral Trauma, Hypoxia, Hypoxia, Brain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Respiratory, brain disorder, brain injury, central nervous system disorder, injury, nervous system disorder, nervous system injury | Active, not recruiting | Not applicable | 2026-05-05 | NCT03754114 | |
| Non-interventional Study on Osilodrostat in Patients With Endogenous Cushing's Syndrome | Cushing syndrome, adrenal gland disorder, adrenal gland hyperfunction, endocrine system disorder | Active, not recruiting | Not stated | 2025-11-20 | NCT05382156 | |
| Early Versus Late Endoscopic Stenting for Refractory Benign Esophageal Strictures | Refractory Benign Esophageal Strictures | Recruiting | Not applicable | 2025-10-30 | NCT06991049 | |
| Evaluating Pain Control Strategies in Postpartum Patients on Opioid Use Disorder Medications. | Chemically-Induced Disorders, psychiatric disorder, substance-related disorder | Recruiting | Early phase 1 | 2025-10-23 | NCT06617949 | |
| Evaluating the Effects of Genetic Testing on Patients' Stress Levels | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Not stated | 2025-10-09 | NCT02783664 | |
| Understanding the Implementation of Cued Exercise Using Wearable Devices and a Custom Smartphone Application Following Bone Marrow Transplant. | Hemic and Lymphatic Diseases, Neoplasms by Site, hematologic disorder, hematopoietic and lymphoid system neoplasm, neoplasm | Active, not recruiting | Not applicable | 2025-02-14 | NCT06645132 | |
| EMST in Patients Undergoing CRT for HNCA | Deglutition Disorders, Digestive System Diseases, Head and Neck Neoplasms, Neoplasms by Site, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Stomatognathic Diseases, digestive system disorder, esophageal disorder, laryngeal disorder, laryngeal neoplasm, neoplasm, otorhinolaryngologic disease, respiratory system disorder, respiratory tract neoplasm | Recruiting | Not applicable | 2024-12-04 | NCT03916809 | |
| Botulinum Toxin A for the Treatment of Chemotherapy Induced Peripheral Neuropathy | Peripheral Neuropathy Due to Chemotherapy | Recruiting | Phase 2 | 2021-12-23 | NCT03571334 |